Literature DB >> 25934208

Management of complications of Dupuytren contracture.

Kevin Cheung1, Kempland C Walley2, Tamara D Rozental3.   

Abstract

This evidence-based article discusses the current management options of Dupuytren disease and strategies to avoid and manage any potential complications. Treatment options include fasciectomy, needle fasciotomy/aponeurotomy, and collagenase injection. Complications include digital nerve and artery injury, flexor tendon injury, skin fissures and wound healing complications, hematoma, infection, flare reaction/complex regional pain syndrome, and recurrence. Complication rates, prevention, and management differ with each treatment modality. A detailed understanding of each of these options allows hand surgeons to select the most appropriate treatment for each patient.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Collagenase injection; Complications; Dupuytren disease; Fasciectomy; Management; Needle aponeurotomy; Recurrence

Mesh:

Year:  2015        PMID: 25934208     DOI: 10.1016/j.hcl.2015.01.005

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  10 in total

Review 1.  Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Authors:  Marc D Lipman; Samuel Evan Carstensen; Dylan Nicole Deal
Journal:  Hand (N Y)       Date:  2016-05-03

Review 2.  [Primary intervention in Dupuytren's disease].

Authors:  U S Vesper; I M Mehling; A Arsalan-Werner; M Sauerbier
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 3.  [Treatment of recurrent Dupuytren's disease].

Authors:  T Pillukat; L Walle; R Stüber; J Windolf; J van Schoonhoven
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

4.  Phalangeal fracture leading to digital amputation, sustained during manipulation for Dupuytren's disease as part of clostridial collagenase treatment.

Authors:  K Richards; C Sethu; E Tiernan
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

5.  RANDOMIZED CONTROLLED TRIAL OF LIMITED FASCIOTOMY WITH INJECTION OF ADIPOSE GRAFT FOR DUPUYTREN'S DISEASE.

Authors:  Marina Tommasini C Sambuy; Hugo A Nakamoto; Raul Bolliger; Rames Mattar; Marcelo R Rezende; Teng Hsiang Wei
Journal:  Acta Ortop Bras       Date:  2020 Jul-Aug       Impact factor: 0.513

6.  Intra-articular collagenase injection increases range of motion in a rat knee flexion contracture model.

Authors:  Kayleigh Wong; Guy Trudel; Odette Laneuville
Journal:  Drug Des Devel Ther       Date:  2017-12-21       Impact factor: 4.162

7.  Surgical treatment results for dupuytren's disease.

Authors:  Serkan Aykut; Mehmet Baydar; Abdul Fettah Büyük; İbrahim Avşin Öztürk; Erdem Özden; Kahraman Öztürk
Journal:  Acta Ortop Bras       Date:  2017 May-Jun       Impact factor: 0.513

8.  Risk Factors for Dupuytren's Contracture: A Case-Control Study.

Authors:  Liangxiao Zheng; Dongliang Chen; Peng Liu; Jinwei Liu; Xiaofeng Song; Zengfang Zhang
Journal:  Comput Intell Neurosci       Date:  2022-04-28

9.  Epineural Methylene Blue Injection May Aid Localization of Digital Nerves in Dupuytren's Surgery.

Authors:  Tamás Szabó; Viktória Kormos; Zoltán Rékási; Balázs Gaszner
Journal:  Eur Surg Res       Date:  2021-10-22       Impact factor: 1.114

10.  Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren's Disease.

Authors:  Takuro Kuboi; Tsuyoshi Tajika; Fumitaka Endo; Wataru Goto; Ichiro Nakajima; Satoshi Hasegawa; Daisuke Nakajima; Takafumi Hasokawa; Hirotaka Chikuda
Journal:  Prog Rehabil Med       Date:  2021-05-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.